Financial results - FOUR MER PHARMA SRL

Financial Summary - Four Mer Pharma Srl
Unique identification code: 36827034
Registration number: J12/4323/2016
Nace: 4690
Sales - Ron
252.749
Net Profit - Ron
26.861
Employees
1
Open Account
Company Four Mer Pharma Srl with Fiscal Code 36827034 recorded a turnover of 2022 of 252.749, with a net profit of 26.861 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Four Mer Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 106.658 101.141 124.898 1.022.607 405.798 254.942 - -
Total Income - EUR - - 107.718 101.144 125.528 1.022.702 405.810 261.913 - -
Total Expenses - EUR - - 91.091 96.475 105.765 785.216 280.644 221.984 - -
Gross Profit/Loss - EUR - - 16.627 4.669 19.763 237.486 125.166 39.929 - -
Net Profit/Loss - EUR - - 15.550 3.634 18.503 225.698 107.543 27.094 - -
Employees - - 1 1 2 1 1 1 - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -37.4%, from 405.798 euro in the year 2021, to 254.942 euro in 2022. The Net Profit decreased by -80.782 euro, from 107.543 euro in 2021, to 27.094 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Four Mer Pharma Srl

Rating financiar

Financial Rating -
FOUR MER PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Four Mer Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Four Mer Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Four Mer Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Four Mer Pharma Srl - CUI 36827034

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 13 0 0 0 12.118 8.230 - -
Current Assets - - 34.491 63.422 81.987 364.922 412.585 224.671 - -
Inventories - - 4.703 13.455 38.451 128.767 58.678 2.347 - -
Receivables - - 22.880 38.031 22.427 184.492 212.963 127.294 - -
Cash - - 6.909 11.935 21.109 51.663 140.944 95.030 - -
Shareholders Funds - - 15.501 18.850 36.988 225.839 328.373 185.085 - -
Social Capital - - 44 43 42 41 40 41 - -
Debts - - 19.019 44.572 45.112 139.255 96.450 48.100 - -
Income in Advance - - 0 0 0 0 0 0 - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4690 - 4690"
CAEN Financial Year 4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 224.671 euro in 2022 which includes Inventories of 2.347 euro, Receivables of 127.294 euro and cash availability of 95.030 euro.
The company's Equity was valued at 185.085 euro, while total Liabilities amounted to 48.100 euro. Equity decreased by -144.307 euro, from 328.373 euro in 2021, to 185.085 in 2022.

Risk Reports Prices

Reviews - Four Mer Pharma Srl

Comments - Four Mer Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.